Neurocrine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.
NBIX Key Statistics
Stock Snapshot
Neurocrine(NBIX) stock is priced at $154.25, giving the company a market capitalization of 15.68B. It carries a P/E multiple of 22.37.
As of 2026-08-17, Neurocrine(NBIX) stock has fluctuated between $150.69 and $154.81. The current price stands at $154.25, placing the stock +2.4% above today's low and -0.4% off the high.
Neurocrine(NBIX) shares are trading with a volume of 604.3K, against a daily average of 1.35M.
During the past year, Neurocrine(NBIX) stock moved between $122.14 at its lowest and $186.12 at its peak.
During the past year, Neurocrine(NBIX) stock moved between $122.14 at its lowest and $186.12 at its peak.
NBIX News
Deutsche Bank lowered the firm’s price target on Neurocrine (NBIX) to $165 from $190 and keeps a Hold rating on the shares. The firm believes the Vykat commerci...
Earlier this month, Neurocrine Biosciences reported Phase 4 KINECT-PRO results showing once-daily INGREZZA improved patient-reported quality of life, functionin...
Shares of Neurocrine Biosciences (NBIX) slipped in the premarket on Wednesday after safety concerns linked to Vykat XR, a rare disease therapy the company added...
Analyst ratings
90%
of 30 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.